Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Status:
Terminated
Trial end date:
2019-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out what effects, good and/or bad, dose-dense
(every 14 days) chemotherapy with gemcitabine (gemcitabine hydrochloride) and cisplatin given
before surgery have on patients and their muscle invasive bladder cancer.